Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits☆
References (14)
- et al.
Jpn. J. Opthalmol.
(1997) - et al.
Life Sci.
(1996) - et al.
FEBS Lett.
(1994) - et al.
Exp. Eye Res.
(1997) - et al.
Exp. Eye Res.
(1984) - et al.
J. Am. Med. Assn.
(1971) J. Ocular Pharmacol.
(1986)
Cited by (69)
Is fat the future for saving sight? Bioactive lipids and their impact on glaucoma
2023, Pharmacology and TherapeuticsCannabinol modulates neuroprotection and intraocular pressure: A potential multi-target therapeutic intervention for glaucoma
2022, Biochimica et Biophysica Acta - Molecular Basis of DiseaseCitation Excerpt :By acting through the pre-synaptic CB1R, Δ9-THC inhibited the release of glutamic acid. Whereas WIN55212-2 displayed a reduced effect on IOP lowering in the presence of CB1R antagonist SR14716A [61,85,86]. In the case of acute IOP-induced retinal ischemia, cannabinoids produce a neuroprotective effect in these cells via CB1R and TRPV1 receptors [85,87].
The arguments for and against cannabinoids application in glaucomatous retinopathy
2017, Biomedicine and PharmacotherapyCitation Excerpt :Endocannabinoids may regulate spontaneous transmitter that is important in network maintenance in amacrine cells and other inhibitory interneurons [13,60]. Topical administration of synthetic CB1 agonist causes IOP drop in rabbits, non-human primates, and glaucomatous human [61–63], through decrease of aqueous humor flow and inhibition of their inactivation by FAAH or cellular reuptake [64,65]. Cannabinoids modulate release of several neurotransmitters in the retina such as dopamine, glutamate, gamma aminobutyric acid (GABA), and noradrenaline [66–69].
Cannabinoid Regulation of Intraocular Pressure: Human and Animal Studies, Cellular and Molecular Targets
2017, Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and TreatmentCannabinoid applications in glaucoma
2011, Archivos de la Sociedad Espanola de OftalmologiaBiodegradable hybrid polymeric membranes for ocular drug delivery
2010, Acta Biomaterialia
- ☆
This work was supported by grants from the Academy of Finland and the Technology Development Center (Finland).